This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Precision Medicine Conference" (IPMC 2023) scheduled during April 24-26, 2023 in Orlando, Florida, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at precision-medicine@magnusconference.com or call + 1 (702) 988 2320.
Cardiology is a discipline of medicine that focuses on issues with the heart and other components of the circulatory system. Congenital heart defects, coronary artery disease, heart failure, valvular heart disease, and electrophysiology are all included in this field. Any substance that affects the function of the heart and blood arteries is referred to as a cardiovascular drug. Drugs that affect the cardiovascular system are some of the most commonly prescribed in medicine. Cardiovascular medicine has come a long way in the previous few decades, allowing entire populations to live longer and have a higher quality of life. Precision medicine is an integrative approach to cardiovascular disease prevention and treatment that takes into account an individual's genetics, lifestyle, and environmental factors as determinants of their cardiovascular health and disease phenotypes.
Title : Copper (II) complexes as potential anticancer agents
Salah S Massoud, University of Louisiana, United States
Title : Leveraging blockchain technology, edge computing and federated learning to enhance outcomes in precision medicine
Ingrid Vasiliu Feltes, MEDNAX, United States
Title : The new horizons in the patient- centered care for understanding of the reasons of its health problems – Psychosynthesis approach
Ewa Danuta Bialek, Institute of Psychosynthesis, Poland
Title : Hegazy theory for interpretation of human parthenogenesis: A new hypothesis
Abdelmonem Awad Hegazy, Zagazig University, Egypt
Title : Precision Oncology and Personalised Medicine: Innovative Technology for the Treatment of Colorectal Cancer
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : The role of CD44v6 as a new immunotherapy target for urothelial cancer
Iris Adriana Maria Lodewijk, Institute of Biomedical Research, Spain